Congress |#ASH23 Alice Mims, @OSUCCC_James presents a retrospective analysis of the survival outcomes of adult patients with ND AML who received either frontline intensive chemotherapy followed by oral azacitidine maintenance or frontline venetoclax + azacitdine and achieved remission. Patients treated with intensive chemotherapy followed by oral azacitidine maintenance had significantly better survival outcomes than patients treated with venetoclax + azacitidine. #leusm #AMLsm
We met old friends,mentors, mentees and now rising hematologists, made new friends and enhanced our collaborations! Overwhelmed by the new ideas inspired by #ASH22 and can’t wait to bring it to fruition!Until next time @ASH_hematology! @MegLanger@DeannaHuffmanDO@chahine_zena
What an honor it is to be recognized as a, “Rising Star” by the University of Pittsburgh School of Pharmacy-The institution which laid the foundation for my successess and achievements in the profession of pharmacy. @pittpharmacy@PittTweet 💙💛
#h2p#pharmacy#pittpharmacy
Congenital dysfibrinogenemia is a rare but potentially serious condition that can cause pregnancy complications. A NEW #RPTHCaseReport discusses the successful use of fibrinogen replacement therapy in one patient… https://t.co/445TrIv9DS @MegLanger@yazansamhouri@deepshah88
Have you read the latest #RPTHCaseReport by @MegLanger@yazansamhouri & @deepshah88? Congenital dysfibrinogenemia & the use of replacement therapy to avoid complications in pregnancy – a multidisciplinary approach for ideal care is needed for these pts! https://t.co/445TrIv9DS